Clinical study of Yijinjing on improving anxiety and depression in patients with asymptomatic infection of COVID-19 during isolation period

Clinical study of Yijinjing on improving anxiety and depression in patients with asymptomatic infection of new coronary pneumonia during isolation period

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058788

Enrollment

Unknown

Registered

2022-04-17

Start date

2022-04-15

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona Virus Disease 2019

Interventions

Experimental group:basic care and Yijinjing exercise

Control group:basic care

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old, <= 65 years old; 2. Willing to participate in this research and sign the informed consent; 3. Meet the diagnostic criteria for asymptomatic infection of COVID-19.

Exclusion criteria

Exclusion criteria: 1. Severe liver and kidney insufficiency, severe cardiovascular disease; 2. Patients with mental illness; 3. Receive any treatment for anxiety or depression within two weeks; 4. Acute trauma, fracture, etc., who are unable to practice exercises; 5. Moderate depression and suicidal tendencies.

Design outcomes

Primary

Measure	Time frame
Hamilton Anxiety Scale;Hamilton Depression Scale;	—

Countries

China

Contacts

Public ContactXing Hua

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

yyyyxinghua@shuctm.edu.cn+86 21 65161782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026